Allgens Medical
BONGOLD Co-12
Product information
The bio-mimetic bone material closest to autologous bone
Key ingredients
- Purified collagen type I55% ± 5%
- Low-crystallinity nano-hydroxyapatite (n-HA)45% ± 5%
Core technology
Ex-vivo biomimetic mineralization technology
Synthesizes collagen type I and nano-hydroxyapatite outside the body into a microstructure resembling natural bone (hydroxyapatite c-axis aligned parallel to collagen fibers). Developed from Tsinghua University research under China's National 863 Program, covered by Chinese patent ZL01129699.2 and US patent US6,887,488B2.
Information provided by the manufacturer Allgens Medical Technology Co., Ltd., describing raw material and technology characteristics. This is not a declaration of therapeutic effects.
Packaging
Rod form. Code G104502: φ 4mm x L40mm, 1cc/box. Code G105002: φ 5mm x L40mm, 1.5cc/box. Code G106402: φ 5.5mm x L40mm, 2cc/box.
Downloads
Regulatory information
- Medical device name
- Artificial bone
- Classification
- Medical device class D
- Product code
- Co-12
- Declaration number
- 2500502/ĐKLH-BYT-HTTB
- Declaration date
- 13/03/2025
- Product owner
- Allgens Medical Technology Co., Ltd. - 2nd Building, No. 26 Yongwang West Road, Daxing District, 102609 Beijing, China
- Exclusive distributor in Vietnam
- THE HANGI VIET NAM COMPANY LIMITED - 62 Tran Quang Khai St., Tan Dinh Ward, District 1, Ho Chi Minh City
- Origin
- China
BONGOLD Co-12 is a rod form artificial bone graft material from Allgens Medical (China), synthesized from mineralized collagen that mimics the structure of natural bone. It is classified as a class D medical device and holds a circulation registration certificate issued by Vietnam’s Ministry of Health.
Detailed indications, contraindications and usage instructions are provided in the manufacturer’s documentation, intended for healthcare professionals and professional partners.
Last updated: 14/09/2026